Tscan Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Tscan Therapeutics (TCRX) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Tscan Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Tscan Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Tscan Therapeutics by UBS Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $8.3k | 1.4k | 5.83 |
2023-09-30 | $2.9k | 1.1k | 2.56 |
2023-06-30 | $2.8k | 1.1k | 2.50 |
2023-03-31 | $6.8k | 3.2k | 2.10 |
2022-12-31 | $1.6k | 1.0k | 1.55 |
2022-09-30 | $11k | 3.4k | 3.20 |
2022-06-30 | $4.0k | 1.1k | 3.48 |
2021-12-31 | $4.0k | 811 | 4.93 |
2021-09-30 | $8.0k | 946 | 8.46 |